The cancer genomic sequencing data suggests that residues in the ATP-binding site and CH-domain (i.e., UPF2 interacting interface) of the UPF1 protein are frequently mutated, and we assessed the effects of those mutations on UPF1using in silico methodologies. Here, UPF1 is linked to cancer.